Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362031
Status:
WITHDRAWN
Last Update Posted:
2024-04-12
First Post:
2023-05-31
Brief Title:
A Study to Explore Treatment Patterns Treatment Outcomes Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia AML Receiving Venetoclax Through Chart Review
Sponsor:
AbbVie
Organization:
AbbVie
Study Overview
Official Title:
A Center-Based Chart Review Study to Assess Treatment Outcomes of Venetoclax for the Treatment of Acute Myeloid Leukemia AML
Status:
WITHDRAWN
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Strategic considerations
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Acute myeloid leukemia AML also referred to as acute myelogenous leukemia or acute non-lymphocytic leukemia is a relatively rare yet aggressive type of cancer This study will evaluate treatment patterns treatment outcomes healthcare resource utilization in adult participants with AML receiving venetoclax
Data from up to 700 participants will be collected No participants will be enrolled in this study
Participants charts will be reviewed No drug will be administered as a part of this study The duration of the observation period is up to 10 months
There is no additional burden for participants in this trial All visits must be completed prior to data extraction and participants will be followed for up to 10 months
Data from up to 700 participants will be collected No participants will be enrolled in this study
Participants charts will be reviewed No drug will be administered as a part of this study The duration of the observation period is up to 10 months
There is no additional burden for participants in this trial All visits must be completed prior to data extraction and participants will be followed for up to 10 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None